Article
ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C.
TSitologiia i genetika - 1 Jan 2000
Kucherenko A, Pampukha V, Bobrova I, Moroz L, Livshits L
Abstract excerpt
The aim of this study was to clarify the association between the inosine triphosphate pyrophosphatase (ITPA) gene variants and PEG-IFNalpha/RBV combination treatment induced anemia in chronic hepatitis C (CHC) Ukrainian patients. The data were collected from 80 CHC patients with HCV genotype 1 infection. All study participants received standard doses of PEG-IFNalpha and RBV According to the Hb level changes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.